Israeli startup QuantHealth provides a platform for simulating clinical trials to accelerate and de-risk drug development. Their In-Silico platform generates synthetic evidence for therapy performance across all clinical phases. This synthetic evidence-generation engine supports trial planning, indication selection, drug repurposing, and in-licensing asset evaluation.